Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

10
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

13
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
13
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

16
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
16

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing characteristics and outcomes in admissions with pulmonary embolism and inflammatory bowel disease: a national cohort study.

Proceedings (Baylor University. Medical Center)·2026
Same author

The weekend effect in sepsis and septic shock: a 5-year US national study.

Proceedings (Baylor University. Medical Center)·2026
Same author

Cardiogenic Shock Centers and Protocols for Acute Cardiovascular Care: Bridging the Gap Between Spoke and Hub Sites.

Cardiology and therapy·2026
Same author

Syncope During Cycling.

JACC. Case reports·2026
Same author

Etiology, Management, and Outcomes of Society for Cardiovascular Angiography and Interventions Stage B Cardiogenic Shock.

Circulation. Heart failure·2026
Same author

Cardiogenic Shock Detection Using Electronic Medical Records: A Review and Blueprint for Clinical Implementation and Future Research.

Journal of the American Heart Association·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Diagnostic reasoning in clinical neurology: a comprehensive primer.

Postgraduate medical journal·2026
Same journal

Asthma therapy over 100 years.

Postgraduate medical journal·2026
Same journal

Transformation of trauma and orthopaedics across the six industrial revolutions: from mechanization to artificial intelligence applications in enhancing patient care.

Postgraduate medical journal·2026
Same journal

Increased food prices and changes in food consumption behavior: an early precursor to malnutrition, and widespread food insecurity among the Egyptian population.

Postgraduate medical journal·2026
Same journal

Acute kidney injury in rhabdomyolysis defined by serum creatine kinase ≥1000 IU/L: association with creatine kinase levels.

Postgraduate medical journal·2026
See all related articles

Related Experiment Video

Updated: Jul 26, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.6K

Myocarditis post-COVID-19 vaccination.

Mridul Bansal1, Aryan Mehta1, Mandvi Pandey2

  • 1Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, United States.

Postgraduate Medical Journal
|June 19, 2023
PubMed
Summary
This summary is machine-generated.

Post-COVID-19 vaccination, myocarditis is a rare but relatively frequent adverse event. This review examines the association between COVID-19 vaccines and myocarditis to clarify the pathology and reduce concerns.

Keywords:
COVID-19myocarditisvaccine adverse events

More Related Videos

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

12.9K
Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

13.1K

Related Experiment Videos

Last Updated: Jul 26, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.6K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

12.9K
Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

13.1K

Area of Science:

  • Immunology
  • Vaccinology
  • Cardiology

Background:

  • The rapid development of coronavirus disease 2019 (COVID-19) vaccines has spurred interest in potential adverse events.
  • Myocarditis following COVID-19 vaccination has emerged as a notable concern.
  • Proposed pathophysiological mechanisms link mRNA vaccines to myocarditis, but a causal relationship is not yet definitively established.

Purpose of the Study:

  • To review existing literature on the association between COVID-19 vaccination and myocarditis.
  • To elucidate current understanding of the relationship between COVID-19 vaccines and myocarditis.
  • To inform on the burden of myocarditis post-vaccination and alleviate public apprehension.

Main Methods:

  • Literature review of studies investigating COVID-19 vaccination and myocarditis.
  • Analysis of proposed pathophysiological mechanisms.
  • Evaluation of incidence rates (absolute and relative) of myocarditis post-vaccination.

Main Results:

  • While the absolute incidence of myocarditis post-COVID-19 vaccination is low in the general population, the relative incidence has been noted as high.
  • Several potential mechanisms linking mRNA vaccines to myocarditis have been proposed.
  • The causal link between COVID-19 vaccination and myocarditis requires further investigation.

Conclusions:

  • Understanding the association between COVID-19 vaccination and myocarditis is crucial.
  • Further research is needed to confirm the causal link and refine risk-benefit assessments.
  • This review aims to provide a clearer picture of myocarditis post-vaccination to manage public health concerns.